Global Age-related Vision Dysfunction Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Drug (Eylea, Lucentis, Combigan, Beovu and Other Drugs), Dysfunction Type, Distribution Channel, Region, By Country: 2020-2030

Global Age-related Vision Dysfunction Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Drug (Eylea, Lucentis, Combigan, Beovu and Other Drugs), Dysfunction Type, Distribution Channel, Region, By Country: 2020-2030

Background

A report published by Azoth Analytics highlights different factors and opportunities prevailing in the “Global Age-related Vision Dysfunction Market (2024 Edition)”. According to the report, Global Age-related Vision Dysfunction Market was valued at USD 90120.66 Million and is expected to grow at a CAGR of 4.7% during 2025-2030.

The report explores a multi-faceted opportunity landscape in terms of market segmentation by Drug (Eylea, Lucentis, Combigan, Beovu and Other Drugs), By Dysfunction Type (Glaucoma, Cataract, Presbyopia and AMD) and By Distribution Channel (Online Pharmacies and Retail Pharmacies )

Market Overview

The Age-related Vision Dysfunction market has seen considerable growth due to the increasing prevalence of age-related eye diseases, the growing aging population, and advancements in diagnostic and therapeutic technologies. Age-related vision dysfunction encompasses various conditions such as age-related macular degeneration (AMD), cataracts, glaucoma, and diabetic retinopathy. The market is driven by the need for effective diagnosis, management, and treatment of these conditions to improve the quality of life for elderly patients.

One of the primary drivers of the Age-related Vision Dysfunction market is the rising prevalence of age-related eye diseases. As the global population ages, the incidence of conditions like AMD, cataracts, and glaucoma increases, leading to greater demand for medical interventions. The growing awareness of these conditions and the importance of regular eye exams have also contributed to market growth, as early detection and treatment can prevent or slow the progression of vision loss.

The increasing focus on innovative treatment options and the development of advanced diagnostic technologies have significantly influenced the market. New therapies, such as anti-VEGF injections for AMD and minimally invasive glaucoma surgeries, offer improved outcomes and fewer side effects. Additionally, advancements in imaging technologies, like optical coherence tomography (OCT), have enhanced the ability to diagnose and monitor eye diseases accurately.

Segment Insights

By dysfunction type, the age-related macular degeneration (AMD) segment holds the largest market share, accounting for approximately 45% of the global Age-related Vision Dysfunction market in 2023. The high prevalence of AMD among the elderly population and the availability of effective treatments drive this segment.

Geographical Insights

Americas represent the largest market for Age-related Vision Dysfunction treatments, driven by a high prevalence of age-related eye diseases, advanced healthcare infrastructure, and strong investment in ophthalmology research. The United States is a key market, with a significant focus on developing new treatments and improving patient care.

In the Americas, the market benefits from a well-established healthcare system, increasing public awareness, and the presence of major pharmaceutical and medical device companies. The growing aging population and the high incidence of conditions like AMD and glaucoma further support market growth.

The Asia Pacific region is expected to witness the highest growth rate, driven by the rapidly aging population, increasing healthcare expenditures, and rising awareness of age-related eye diseases. Countries like China, Japan, and South Korea are key markets, with expanding healthcare infrastructure and a focus on improving access to eye care services.

In Europe, the market for Age-related Vision Dysfunction treatments is driven by strong healthcare systems, high patient awareness, and the availability of advanced therapeutic options. Countries like Germany, France, and the UK are significant contributors, with a focus on research and development in ophthalmology

Market Segmentation

By Drug:

• Eylea
• Lucentis
• Combigan
• Beovu
• Other Drugs

By Dysfunction Type:

• Glaucoma
• Cataract
• Presbyopia
• AMD

By Distribution Channel:

• Online Pharmacies
• Retail Pharmacies

By Geography

• Americas (The United States, Canada, Brazil, Mexico, Rest of Americas)
• Europe (United Kingdom, Germany, France, Italy, Spain, Turkey, Russia, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Singapore, Indonesia, Rest of Asia Pacific)
• Middle East and Africa (GCC, Israel, South Africa, Rest of Middle East and Africa)

Key Companies

The report assesses the competitive developments, strategies, mergers and acquisitions and new product development and market share portfolio of top 15 companies. Key companies in the Global Age-related Vision Dysfunction Market include:

• Bausch + Lomb
• D Western Therapeutics Institute
• Novartis
• IVERIC Bio
• Santen Pharmaceutical
• AbbVie
• Aerie Pharmaceuticals
• Eyenovia
• Sun Pharma Advanced Research Company Limited
• Orasis Pharmaceuticals
• Other Leading Companies

Reasons to buy this report:

• In-Depth Comparative Assessment of Top 20 Markets in the Age-related Vision Dysfunction Market: Comparative assessment of 20 leading countries highlighting the total addressable market, opportunities, lucrative segments and competitive positioning of leading companies.
• Comprehensive Historical, Present, and Future Analytics of the Age-related Vision Dysfunction Market: A deep dive in the historical (2020-2023), current (2024) and forecast (2025-2030) market analytics of Age-related Vision Dysfunction Market.
• Detailed Analysis of Age-related Vision Dysfunction Market By Drug, Dysfunction Type, and Distribution Channel Across 20 Countries
• Beyond the Purchase: 90 Days of Support
• Direct Access to Analysts: Have questions after reading the report? Our expert analysts are just a call or email away.
• Customized Assistance: Whether you're integrating insights into your strategy or have questions about market dynamics, our team provides tailored support to meet your specific business needs.
• Data Customization Requests: During the support period, you have the flexibility to request additional data cuts or deeper dives into specific areas of interest.
• Gain insights specific to new entrants or new market areas to tap: The study provides detailed market entry strategies, including analysis of barriers to entry, pricing strategies, opportunities, trends, drivers, and challenges and product positioning using the Opportunity Portfolio Matrix (OPM)
• Strategic Company Movements: Tracking Competitive Developments and Key Players in the Market: The report covers competitive strategies, mergers & acquisitions, new developments, future plans and market share analysis of ~15 top companies.

*Please Note: The report will be delivered in 2 business days upon order confirmation*